Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer

Clinical Trial ID NCT00982592

Rank	Title	Journal	Year	PubWeight™‹?›
1	G protein-coupled receptors: novel targets for drug discovery in cancer.	Nat Rev Drug Discov	2011	3.31
2	Unraveling the therapeutic potential of the Hedgehog pathway in cancer.	Nat Med	2013	2.55
3	Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.	Nat Rev Clin Oncol	2015	2.02
4	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
5	Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?	Oncologist	2012	1.10
6	Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.	Oncotarget	2015	0.97
7	Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.	Clin Cancer Res	2015	0.96
8	Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors.	Cancers (Basel)	2016	0.91
9	Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.	Expert Rev Mol Med	2015	0.87
10	Investigational agents in metastatic basal cell carcinoma: focus on vismodegib.	J Exp Pharmacol	2012	0.75
11	Novel therapy for advanced gastric cancer.	World J Gastrointest Oncol	2015	0.75